Frontlight ResearchEarly access
CompletedNo phase
Developement of TipTraQ Home Sleep Test
Key facts
- Who runs it
- PranaQ Pte. Ltd.
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 240 people enrolled
- Started
- 1 Jun 2023
- Ended
- 31 Dec 2023
- Type of study
- Observational
- Record updated
- 22 October 2024
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Subjects from the age of 20 and older that have an indication for an in-lab PSG study. The subject should be able to understand the study and sign the informed consent before being enrolled in the study. During the study period, the subject can withdraw from the study any time
Who cannot take part
- Chronic opioid medication user Devastating Severe strokes, with the modified Rankin score (mRS)≥4
- Subjects with the following medical conditions will be excluded from this study:
- Heart transplant
- Heart failure, New Youk Heart Association (NYHA) classification III or IV
- Tracheostomy
- Incapable of comprehending and signing the informed consent and questionnaires, including but not limited to subjects with severe Alzheimer's, unconscious by head trauma, or of someone with limited mental capacity
- Cannot correctly follow the order to use the TipTraQ device
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The clinical study aims to develop and fine-tune the TipTraQ system, created by PranaQ, for home sleep apnea screening. The system comprises a wearable device and a cloud-based AI for estimating Total Sleep Time (TST) and Apnea-Hypopnea Index (AHI). This open-label, non-randomized study will recruit 240 subjects aged 20 and older from the Veteran General Hospital, Taipei.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Development and Fine-tuning of a Medical-grade Wearable Device with Interpretable Artificial Intelligence System for the Obstructive Sleep Apnea-hypopnea Syndrome (OSAHS) Screening
- Publications
- Record updated
- 22 October 2024